-
Antibiotics Can Be Used During Durvalumab Treatment in Biliary Cancer
“People with advanced BTC can safely be treated with antibiotics while benefiting from treatment with durvalumab plus chemotherapy,” lead author Aiwu He, MD, PhD.
Category: News
-
Engineer Credits Proton Therapy with Beating Stomach Cancer
“They have a great team approach at MedStar Georgetown with an oncologist, surgeon, and radiation therapist,” explains Jack. They told me that because of where my tumor was, I was a great candidate for proton therapy instead of standard radiation.”
Category: News
-
Advancements in the treatment of gastrointestinal cancers
What are some recent advancements in targeted treatments for gastrointestinal cancers? Dr. Benjamin Weinberg discusses clinical trials aimed at treating GI cancers more effectively
Category: News
-
Durvalumab Triplet Improves OS Across Biliary Tract Cancer Locations
Dr. Aiwu Ruth He discusses her recent Biliary Tract Cancer Research that was featured in NEJM Evidence
Category: News
-
Medical Costs and Clinical Value: Playing the Long Game
Even as soaring medical costs strain public and private budgets around the world, patients yearn for therapeutic breakthroughs. Game-changing cancer treatments, emerging antiviral agents, and mRNA vaccines are powerful reminders of medical technology’s potential. But insurance premiums and out-of-pocket payments underscore medicine’s financial burden.
Category: News
-
Durvalumab Plus Chemotherapy Maintains OS Benefit in Advanced Biliary Tract Cancer
Dr. Aiwu Ruth He discusses her biliary tract cancer research presented at ESMO GI
Category: News
-
GI Oncology at ASCO 2022: Tumor Sidedness, ctDNA, and MRD
Dr. John L. Marshall and Dr. Mark A. Lewis discuss the most interesting GI research from ASCO 2022
Category: News
-
Use of Circulating Tumor DNA to Assess Minimal Residual Disease in Gastrointestinal Cancers
Circulating tumor DNA (ctDNA) is a promising, non-invasive biomarker with the potential to identify the earliest signs of cancer relapse.
Category: News
-
Trends and Disparities in Treatment Approaches for Patients With Locoregional ESCC
Dr. Marshall shared insights on contemporary approaches to treating localized ESCC and existing racial disparities in treatment.
Category: News
-
A Survey of Patient Presentation, Testing, and Diagnosis in ESCC
Broad discussion from John Marshall, MD, on the current standards of diagnosis care in esophageal squamous cell carcinoma (ESCC).
Category: News